Brinkmann, Volker and Baumruker, Thomas (2006) Pulmonary and vascular pharmacology of sphingosine 1-phosphate. Current Opinion in Pharmacology, 6 (3). pp. 244-250. ISSN 1471-4892

Abstract

Dysregulation of vasomotor tone, endothelial barrier function and immune cell trafficking are central to the pathology of many lung diseases, including acute lung injury, adult respiratory distress syndrome, chronic obstructive pulmonary disease and asthma. There is increasing evidence that the serum sphingolipid sphingosine 1-phosphate and its G-protein-coupled receptors are pivotal not only in the regulation of lymphocyte migration, but also in the maintenance of vascular homeostasis and the preservation of permeability barriers that separate discrete compartments in the lung.

Item Type:	Article
Related URLs:	http://www.ncbi.nlm.nih.gov/sites/entrez... doi:10.1016/j.coph.2005.12.004
Additional Information:	author can archive post-print (ie final draft post-refereeing); Publisher's version/PDF cannot be used
Related URLs:	http://www.ncbi.nlm.nih.gov/sites/entrez... doi:10.1016/j.coph.2005.12.004
Date Deposited:	14 Dec 2009 14:00
Last Modified:	31 Jan 2013 01:17
URI:	https://oak.novartis.com/id/eprint/421